Market Exclusive

Allergan plc (NYSE:AGN) gets downgraded to Neutral by UBS Group with a price target of $203.00

ME Staff

Analyst Ratings For

Allergan plc (NYSE:AGN)

Today,

Allergan plc (NYSE:AGN) stock was downgraded by UBS Group from Buy to Neutral with a price target of $203.00.

There are 16 Hold Ratings, 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on

Allergan plc (NYSE:AGN) is Hold with a consensus target price of $175.90 per share, a potential 4.66% downside.

Some recent analyst ratings include

  • 11/19/2019-
    Allergan plc (NYSE:AGN) gets downgraded to Neutral by UBS Group with a price target of $203.00
  • 9/30/2019-
    Allergan plc (NYSE:AGN) had its Outperform rating reiterated by Wells Fargo & Co with a $184.00 price target
  • 8/8/2019-
    Allergan plc (NYSE:AGN) had its Hold rating reiterated by Royal Bank of Canada with a $178.00 price target
  • 8/7/2019-
    Allergan plc (NYSE:AGN) gets downgraded to Neutral by Guggenheim
  • 7/18/2019-
    Allergan plc (NYSE:AGN) had its Outperform ➝ Market Perform rating reiterated by Svb Leerink with a $188.00 price target
    • On 3/7/2019 Brent L Saunders, Chairman, bought 1,760 with an average share price of $143.67 per share and the total transaction amounting to $252,859.20.
    • On 11/16/2018 Matthew M. Walsh, CFO, bought 1,000 with an average share price of $157.00 per share and the total transaction amounting to $157,000.00.
    • On 9/6/2018 Christopher J. Coughlin, Director, bought 10,000 with an average share price of $190.64 per share and the total transaction amounting to $1,906,400.00.
    • On 8/30/2018 Joseph H. Boccuzi, Director, bought 900 with an average share price of $190.59 per share and the total transaction amounting to $171,531.00.
    • On 5/17/2018 William Meury, EVP, sold 24,425 with an average share price of $154.59 per share and the total transaction amounting to $3,775,860.75.
    • On 3/15/2018 Maria Teresa Hilado, Insider, bought 895 with an average share price of $167.39 per share and the total transaction amounting to $149,814.05.
    • On 3/8/2018 Brent L. Saunders, CEO, bought 3,300 with an average share price of $152.53 per share and the total transaction amounting to $503,349.00.

    Recent Trading Activity for

    Allergan plc (NYSE:AGN)
    Shares of
    Allergan plc closed the previous trading session at with 2890800 shares trading hands.